Literature DB >> 10839909

Response surface model for anesthetic drug interactions.

C F Minto1, T W Schnider, T G Short, K M Gregg, A Gentilini, S L Shafer.   

Abstract

BACKGROUND: Anesthetic drug interactions traditionally have been characterized using isobolographic analysis or multiple logistic regression. Both approaches have significant limitations. The authors propose a model based on response-surface methodology. This model can characterize the entire dose-response relation between combinations of anesthetic drugs and is mathematically consistent with models of the concentration-response relation of single drugs.
METHODS: The authors defined a parameter, theta, that describes the concentration ratio of two potentially interacting drugs. The classic sigmoid Emax model was extended by making the model parameters dependent on theta. A computer program was used to estimate response surfaces for the hypnotic interaction between midazolam, propofol, and alfentanil, based on previously published data. The predicted time course of effect was simulated after maximally synergistic bolus dose combinations.
RESULTS: The parameters of the response surface were identifiable. With the test data, each of the paired combinations showed significant synergy. Computer simulations based on interactions at the effect site predicted that the maximally synergistic three-drug combination tripled the duration of effect compared with propofol alone.
CONCLUSIONS: Response surfaces can describe anesthetic interactions, even those between agonists, partial agonists, competitive antagonists, and inverse agonists. Application of response-surface methodology permits characterization of the full concentration-response relation and therefore can be used to develop practical guidelines for optimal drug dosing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839909     DOI: 10.1097/00000542-200006000-00017

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  54 in total

1.  Tolerance to sedative drugs in PICU: can it be moderated or is it immutable?

Authors:  Andrew R Wolf; Bronagh Blackwood; Brian Anderson
Journal:  Intensive Care Med       Date:  2015-11-24       Impact factor: 17.440

2.  Optimization of drug combinations using Feedback System Control.

Authors:  Patrycja Nowak-Sliwinska; Andrea Weiss; Xianting Ding; Paul J Dyson; Hubert van den Bergh; Arjan W Griffioen; Chih-Ming Ho
Journal:  Nat Protoc       Date:  2016-01-14       Impact factor: 13.491

3.  Biphasic characteristic of interactions between stiripentol and carbamazepine in the mouse maximal electroshock-induced seizure model: a three-dimensional isobolographic analysis.

Authors:  Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09-14       Impact factor: 3.000

Review 4.  Population pharmacokinetics/pharmacodynamics of anesthetics.

Authors:  Erik Olofsen; Albert Dahan
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

5.  Response surface methodology in docking study of small molecule BACE-1 inhibitors.

Authors:  Nima Razzaghi-Asl; Ahmad Ebadi; Najmeh Edraki; Ahmadreza Mehdipour; Sara Shahabipour; Ramin Miri
Journal:  J Mol Model       Date:  2012-05-13       Impact factor: 1.810

6.  Synergy: a concept in search of a definition.

Authors:  Hans-Rudolf Berthoud
Journal:  Endocrinology       Date:  2013-09-03       Impact factor: 4.736

7.  Lessons learned from closed loops in engineering: towards a multivariable approach regulating depth of anaesthesia.

Authors:  Clara M Ionescu; Ioana Nascu; Robin De Keyser
Journal:  J Clin Monit Comput       Date:  2013-11-23       Impact factor: 2.502

Review 8.  Pharmacokinetic-pharmacodynamic modelling in anaesthesia.

Authors:  Pedro L Gambús; Iñaki F Trocóniz
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

Review 9.  Assessment of non-linear combination effect terms for drug-drug interactions.

Authors:  Gilbert Koch; Johannes Schropp; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-16       Impact factor: 2.745

10.  Drug interaction: focusing on response surface models.

Authors:  Soo-Il Lee
Journal:  Korean J Anesthesiol       Date:  2010-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.